Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and Treatment.

Kornete M, Mason ES, Piccirillo CA.

Front Endocrinol (Lausanne). 2013 Jun 25;4:76. doi: 10.3389/fendo.2013.00076. eCollection 2013.

2.

Type 1 diabetes: translating mechanistic observations into effective clinical outcomes.

Herold KC, Vignali DA, Cooke A, Bluestone JA.

Nat Rev Immunol. 2013 Apr;13(4):243-56. doi: 10.1038/nri3422. Review.

3.

Virus infections in type 1 diabetes.

Coppieters KT, Boettler T, von Herrath M.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007682. doi: 10.1101/cshperspect.a007682. Review.

4.

Intravital imaging of CTLs killing islet cells in diabetic mice.

Coppieters K, Amirian N, von Herrath M.

J Clin Invest. 2012 Jan;122(1):119-31. doi: 10.1172/JCI59285. Epub 2011 Dec 1.

5.

Oxidative stress and redox modulation potential in type 1 diabetes.

Delmastro MM, Piganelli JD.

Clin Dev Immunol. 2011;2011:593863. doi: 10.1155/2011/593863. Epub 2011 May 18.

6.

Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.

Tanaka S, Nishida Y, Aida K, Maruyama T, Shimada A, Suzuki M, Shimura H, Takizawa S, Takahashi M, Akiyama D, Arai-Yamashita S, Furuya F, Kawaguchi A, Kaneshige M, Katoh R, Endo T, Kobayashi T.

Diabetes. 2009 Oct;58(10):2285-91. doi: 10.2337/db09-0091. Epub 2009 Jul 29.

Items per page

Supplemental Content

Write to the Help Desk